ALUR
What one share of Allurion Technologies holds
Surgical and Medical Instruments and Apparatus
Our company is pioneering metabolically healthy weight loss by creating a best-in-class weight loss platform to treat the estimated two billion people globally who are overweight.
Allurion Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $1.30 |
|---|---|
| Profit | −$3.44 |
| Cash and investments | $0.34 |
| Debt | $2.90 |
| Book value | −$5.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $59.63 | −$37.75 | $1.44 | −$45.07 | — | −$29.83 |
| 2023 | $37.57 | −$59.38 | $1.13 | −$46.08 | — | −$37.38 |
| 2024 | $14.29 | −$3.20 | $0.27 | −$19.10 | — | −$28.77 |
| 2025 | $2.02 | −$3.81 | — | −$3.84 | — | −$6.29 |